إعلان
إعلان

GLSI

GLSI logo

Greenwich LifeSciences, Inc.

25.29
USD
برعاية
+2.88
+12.85%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

25.34

+0.05
+0.20%

تقارير أرباح GLSI

النسبة الإيجابية المفاجئة

GLSI تفوق 11 من 18 آخر التقديرات.

61%

التقرير التالي

بيانات التقرير القادم
١٣ أبريل ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.34
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+13.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-44.26%

Greenwich LifeSciences, Inc. earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, GLSI reported earnings of -0.30 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 0.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an زيادة of 13.33% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Greenwich LifeSciences, Inc. reported EPS of -$0.30, missing estimates by 0.3%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.08%, changed from $8.32 before the earnings release to $8.23 the day after.
The next earning report is scheduled for ١٣ أبريل ٢٠٢٦.
Based on 3 المحللين, Greenwich LifeSciences, Inc. is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان